Pancreatic Cancer Research

ResearcherThe University of TokyoActive in the last 2 years

Takuya Miyazaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1884-4757; OpenAlex author ID A5101904235. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model. Co-author DOI 10.1016/j.jconrel.2024.03.041↗
  2. Boronic Acid Ligands Can Target Multiple Subpopulations of Pancreatic Cancer Stem Cells via pH-Dependent Glycan-Terminal Sialic Acid Recognition. Co-author DOI 10.1021/acsabm.1c00383↗
  3. Phosphorylcholine-Installed Nanocarriers Target Pancreatic Cancer Cells through the Phospholipid Transfer Protein. First author DOI 10.1021/acsbiomaterials.1c00730↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Horacio Cabral · 3 shared papers, 2021–2024 · strength 0.54
  2. Akira Matsumoto · 2 shared papers, 2021 · strength 0.28
  3. Hiroyoshi Y. Tanaka · 1 shared paper, 2024 · strength 0.26
  4. Mitsunobu R. Kano · 1 shared paper, 2024 · strength 0.26
  5. Atsushi Masamune · 1 shared paper, 2024 · strength 0.26
  6. Taehun Hong · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.